Headway, a startup that connects patients to in-network therapists, announced the close of a $125 million Series C funding round on Thursday.
The financing round brings the New York-based company’s total funding amount to $225…
RaySearch Laboratories AB is expanding its collaboration with P-Cure, a proton therapy provider, to integrate its RayStation and RayCare systems with P-Cure’s proton therapy system. This partnership enables seamless use of RaySearch’s automation, workflow…
Continue Reading
GT Medical Technologies, Inc. presented promising interim results from a multi-institutional study at ASTRO 2023, reinforcing the effectiveness and safety of GammaTile Therapy for recurrent brain metastases. The study involved 48 patients from 14…
Continue Reading
Mevion Medical Systems and RaySearch Laboratories are collaborating to pioneer groundbreaking solutions in proton therapy. Their partnership focuses on enhancing treatment planning, supporting adaptive therapy, advancing proton arc therapy, and facilitating FLASH proton therapy….
Continue Reading
A groundbreaking study reveals the effectiveness of liquid biopsy tests in guiding personalized treatment for non-small cell lung cancer (NSCLC) patients. Unlike conventional methods, these tests focus on circulating tumor DNA (ctDNA) levels, providing…
Continue Reading
RaySearch will unveil its latest software innovations at ASTRO 2023 in San Diego from October 1 to 4. Attendees can experience advancements in RayStation’s treatment planning system, RayCare’s oncology information system, and the cloud-based…
Continue Reading
Mevion Medical Systems is set to transform proton therapy at ASTRO 2023 with groundbreaking innovations. They’ve achieved the world’s first proton therapy system designed to fit into traditional LINAC vaults, enhancing accessibility. Collaborating with…
Continue Reading
RefleXion Medical is set to unveil its game-changing RefleXion X1 with SCINTIX biology-guided radiotherapy at the ASTRO 2023 Annual Meeting in San Diego, BOOTH #2831. A robust lineup of 19 scientific presentations by researchers…
Continue Reading
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
Yet another retailer is making moves in healthcare. This time it’s Costco, which announced Monday that it is partnering with virtual health marketplace Sesame to provide Costco members with discount pricing for medical care….
Continue Reading
